Haemonetics has sustainable growth levers in place that are underscored by key product offerings and recent liquidity preservation measures. The company remains insulated from larger names via their e
Haemonetics Corporation (HAE) CEO Chris Simon on Q2 2021 Results - Earnings Call Transcript

Haemonetics: Q2 Earnings Insights

07:11am, Wednesday, 04'th Nov 2020
  Shares of Haemonetics (NYSE:HAE) fell 0.1% in pre-market trading after the company reported Q2 results.
BOSTON, Nov. 4, 2020 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that financial results for its second quarter fiscal 2021, which ended September 26, 2020, are available on its Invest
Nuveen Asset Management LLC cut its stake in shares of Haemonetics Co. (NYSE:HAE) by 67.2% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). Th
PNC Financial Services Group Inc. lowered its position in Haemonetics Co. (NYSE:HAE) by 2.7% in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 7,030 s
Great West Life Assurance Co. Can lessened its holdings in shares of Haemonetics Co. (NYSE:HAE) by 4.2% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Com
Amalgamated Bank lifted its stake in Haemonetics Co. (NYSE:HAE) by 9.2% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm
Synovus Financial Corp acquired a new stake in shares of Haemonetics Co. (NYSE:HAE) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm acquired 7,263 shares of the
Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative hematology solutions to drive better patient outcomes, today announced it will present results
Haemonetics' (HAE) first-quarter fiscal 2021 results reflect impressive performance by Blood Center segment despite dismal overall performance during the coronavirus-led crisis.
It is hard to get excited after looking at Haemonetics' (NYSE:HAE) recent performance, when its stock has declined 26...
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Haemonetics (HAE
Haemonetics (HAE) delivered earnings and revenue surprises of 12.20% and 1.35%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE